Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,650 | -8,310 | -4,020 | -11,430 | -5,740 |
| Depreciation Amortization | 3,520 | 2,380 | 1,240 | 5,910 | 4,080 |
| Other Working Capital | 1,240 | 3,900 | -890 | 10,890 | 11,950 |
| Other Operating Activity | 1,450 | 850 | 260 | 2,820 | 3,420 |
| Operating Cash Flow | $-5,440 | $-1,180 | $-3,410 | $8,190 | $13,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,250 | -2,110 | -730 | -1,770 | -1,530 |
| Other Investing Activity | 5,010 | -100 | -1,310 | -22,490 | -30,690 |
| Investing Cash Flow | $1,760 | $-2,210 | $-2,040 | $-24,260 | $-32,220 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -950 | -1,170 | -1,880 | -1,580 | -3,240 |
| Financing Cash Flow | $-950 | $-1,170 | $-1,880 | $-1,580 | $-3,240 |
| Exchange Rate Effect | -170 | -570 | -370 | -650 | -470 |
| Beginning Cash Position | 8,710 | 8,710 | 8,710 | 27,020 | 27,020 |
| End Cash Position | 3,900 | 3,570 | 990 | 8,710 | 4,780 |
| Net Cash Flow | $-4,800 | $-5,140 | $-7,720 | $-18,300 | $-22,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,440 | -1,180 | -3,410 | 8,190 | 13,710 |
| Free Cash Flow | -5,440 | -1,180 | -3,410 | 8,190 | 13,710 |